Kromek Group PLC - Sedgefield-based detection technology supplier - Begins developing a new system aimed at improving pathological medical imaging techniques used in cancer surgery to distinguish between healthy and non-healthy tissue. This is a new application area for the company's technology and will take place under a three-year project with grant funding from Innovate UK. It is taking place in partnership with Flat Panel X-ray Source developer Adaptix Ltd and the University of Manchester. Kromek's CZT detectors are already incorporated into medical devices used for early detection of diseases like osteoporosis and breast cancer.
CEO Arnab Basu said: "This is an exciting project for Kromek as it takes our CZT-based detectors into a new application area. Our technology is already being used by leading OEMs to enable the early diagnosis of cancer. With this system, we will contribute to improving the outcome of surgeries through greater image quality. It will reduce the risk of diseased tissue remaining and further surgeries being required while minimising the removal of healthy tissue, which will be of great benefit to both healthcare providers and patients. We look forward to working alongside our partners, Adaptix and the University of Manchester, to complete the development of this new system and take it to the next stage."
Current stock price: 12.75 pence
Year-to-date change: down 50%
By Anna Farley; annafarley@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
Kromek (KMK)